PROGENITOR INC
NT 10-K, 1998-12-30
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: SEPARATE ACCOUNT A OF PACIFIC LIFE INSURANCE CO, 497, 1998-12-30
Next: BAY POND PARTNERS L P, SC 13G/A, 1998-12-30



<PAGE>   1
                             SECURITIES AND EXCHANGE
                                    COMMISION

                             Washington, D. C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

                                                Commission file number 000-21215

(Check one)
[x] Form 10-K  [ ] Form 20-F  [ ] Form 11-K  [ ] Form 10-Q  [ ] Form N-SAR
      For period ended 9/30/98
[ ] Transition report on Form 10-K
[ ] Transition report on Form 20-F
[ ] Transition report on Form 11-K
[ ] Transition report on Form 10-Q
[ ] Transition report on Form N-SAR
      For the transition period ended __________
- --------------------------------------------------------------------------------
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
- --------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:  N/A
- --------------------------------------------------------------------------------

                                     PART I
                             REGISTRANT INFORMATION

Progenitor, Inc.
- --------------------------------------------------------------------------------
Full Name of Registrant

Not Applicable
- --------------------------------------------------------------------------------
Former Name if Applicable

4040 Campbell Avenue
- --------------------------------------------------------------------------------
Address of principal executive office

Menlo Park, CA 94025
- --------------------------------------------------------------------------------
City, State and Zip Code

<PAGE>   2

                        PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rules 12b-25(b), the following
should be completed. (Check box if appropriate)

[x]  (a)  The reasons described in reasonable detail in Part III of this form 
          could not be eliminated without unreasonable effort or expense;

[x]  (b)  The subject annual report semi-annual report , transition report on
          Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be
          filed on or before the fifteenth calendar day following the prescribed
          due date; or the subject quarterly report of transition report on Form
          10-Q, or portion thereof will be filed on of before the fifth calendar
          day following he prescribed due date; and

[ ]  (c)  The accountant's statement or other exhibit required by Rule 12b-25
          has been attached if applicable.

                              PART III - NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K,
10-Q, N-SAR, or the transition report or portion thereof, could not be filed
within the prescribed time period. (Attach extra sheets if needed)

On December 18, 1998, the Progenitor, Inc. ("Progenitor", or "the Company")
announced that it was ceasing operations immediately. Progenitor also announced
that it would retain a small staff to implement an orderly sale of the Company's
assets.

During the period leading up to the announcement, the Company's management was
engaged in attempting to identify potential merger partners or financing
sources. Since the announcement, Progenitor's management has been engaged in
making provisions to safeguard assets, transition former employees and identify
consultants to sell the assets.

While the Company had prepared a preliminary draft of the Form 10-K, it was
based on being able to secure financing and continue as a going concern. The
Company is seeking the extension since, under the present circumstances
following the announcement, the Company will have to substantially revise the
disclosures in the preliminary draft of the Form 10-K. Due to Company
circumstances, it would not have been possible to make such changes in a timely
fashion without undue effort or expense.

                           PART IV - OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this
     notification

<PAGE>   3

     Mark Bagnall          (650)          614-7057
     -----------------  -----------   ------------------
      (Name)            (Area Code)   (Telephone number)

(2)  Have all other periodic reports required under Section 13 or 15(d) of the
     Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
     of 1940 during the preceding 12 months or for such shorter period that the
     registrant was required to file such report(s) been filed. If the answer is
     no, identify the report(s).

                                          [x] Yes      [ ] No
     -----------------------------------

(3)  Is it anticipated that any significant change in results of operations from
     the corresponding period of the last fiscal year will be reflected by the
     earnings statements included in the subject report or portion thereof?

                                          [ ] Yes      [x] No

     If so attach an explanation of the anticipated change, both narratively and
     quantitatively, and, if appropriate, state the reasons why a reasonable
     estimate of the results cannot be made.

- --------------------------------------------------------------------------------

                                Progenitor, Inc.
                                ----------------
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date  December 30, 1998                By /s/ Mark N. K. Bagnall
      -----------------                   -------------------------------
                                          Mark N. K. Bagnall
                                          Vice President, Finance and
                                          Chief Financial Officer

INSTRUCTION: This form may be signed by an executive officer of the registrant
or by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is singed on behalf to the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                    ATTENTION
- --------------------------------------------------------------------------------
   Intentional misstatements or omissions of fact constitute Federal Criminal
                        Violations (see 18 U.S.C. 1001)
- --------------------------------------------------------------------------------


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission